All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
An expert panel hosted by
Customizing first-line BTK inhibitors for CLL
with Gilles Salles, Paolo Ghia, and Francesc Bosch
Wednesday, October 23, 2024
18:30-19:30 BST
This independent educational activity is supported by Pharmacyclics LLC, an AbbVie Company and Janssen Biotech. All content is developed independently by the faculty. The funder is allowed no influence on the content of this activity.
The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB and Bristol Myers Squibb: For educational content and news updates.
Jody Quinn is a patient advocate for psoriasis and psoriatic arthritis. She volunteers with several non-profit organizations raising awareness of psoriatic disease. Jody meets with both state and federal agencies in Washington DC and Massachusetts to promote funding for research into psoriatic disease, in order to improve the quality of life for patients and advance legislation that provides better access to treatments and health care providers.
Jody was diagnosed with mild psoriasis and moderate- to- severe psoriatic arthritis after 15 years of suffering and misdiagnosis; and she tells her story to help provide a better understanding for of the disease and highlight the need for early detection.